Related Research Articles
Zidovudine (ZDV), also known as azidothymidine (AZT), was the first antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use in combination with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein.
amfAR, the Foundation for AIDS Research, known until 2005 as the American Foundation for AIDS Research, is an international nonprofit organization dedicated to the support of AIDS research, HIV prevention, treatment education, and the advocacy of AIDS-related public policy.
Armenicum is a drug invented in Armenia in 1998 that its developers claim is an effective treatment for HIV infection and a number of associated diseases. No rigorously monitored clinical trials of Armenicum have been published, and most HIV experts outside of Armenia do not endorse its use.
Jonathan Fishbein is an American physician and former director of the National Institutes of Health (NIH) Office for Policy in Clinical Research Operations. In 2005, Fishbein alleged that an NIH-funded clinical trial of the antiretroviral drug nevirapine, conducted in Africa, was invalid because of poor data collection, faulty record-keeping, and lax quality control. The NIH subsequently attempted to fire Fishbein, and he sought protection as a whistleblower.
With 1.28 percent of the adult population estimated by UNAIDS to be HIV-positive in 2006, Papua New Guinea has one of the most serious HIV/AIDS epidemics in the Asia-Pacific subregion. Although this new prevalence rate is significantly lower than the 2005 UNAIDS estimate of 1.8 percent, it is considered to reflect improvements in surveillance rather than a shrinking epidemic. Papua New Guinea accounts for 70 percent of the subregion's HIV cases and is the fourth country after Thailand, Cambodia, and Burma to be classified as having a generalized HIV epidemic.
HIV Clinical Resource is a health information service in New York State, which provides clinical information and guidance on HIV for the use of healthcare providers and patients.
Michael S. Saag is a physician and prominent HIV/AIDS researcher at the University of Alabama at Birmingham (UAB). He holds the Jim Straley Chair in AIDS Research, is Director of the Division of Infectious Disease and of the William C. Gorgas Center for Geographic Medicine, and Director of the Center for AIDS Research. He is also the founder of the 1917 Clinic, a comprehensive AIDS treatment and research center at UAB Saag is a frequent lecturer at AIDS conferences around the world and is credited with performing pioneering clinical trials for several antiretroviral drugs now in common use for HIV treatment and for first demonstrating the clinical value of "viral-load testing" in HIV/AIDS treatment. In 2009 Saag was elected chairman of the HIV Medicine Association of the Infectious Diseases Society of America. In 2019 Saag began serving on the Presidential Advisory Council on HIV/AIDS.
Lopinavir/ritonavir (LPV/r), sold under the brand name Kaletra among others, is a fixed-dose combination antiretroviral medication for the treatment and prevention of HIV/AIDS. It combines lopinavir with a low dose of ritonavir. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth as a tablet, capsule, or solution.
Patrick Spencer Cox was an American HIV/AIDS activist. He was involved in ACT UP New York and the Treatment Action Group during the height of the AIDS Crisis in New York. He helped facilitate the production of protease inhibitors, which revolutionized AIDS care in the 1990s.
Deborah Persaud is a Guyanese-born American virologist who primarily works on HIV/AIDS at Johns Hopkins Children's Center.
Mary Jane Rotheram-Borus is a licensed clinical psychologist and professor with the University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences. Rotheram is the professor-in-residence in the Semel Institute for Neuroscience and Human Behavior. She is the Director of the Global Center for Children and Families at UCLA and the former director of the Center for HIV Identification, Prevention, and Treatment Services.
HIV in pregnancy is the presence of an HIV/AIDS infection in a woman while she is pregnant. There is a risk of HIV transmission from mother to child in three primary situations: pregnancy, childbirth, and while breastfeeding. This topic is important because the risk of viral transmission can be significantly reduced with appropriate medical intervention, and without treatment HIV/AIDS can cause significant illness and death in both the mother and child. This is exemplified by data from The Centers for Disease Control (CDC): In the United States and Puerto Rico between the years of 2014–2017, where prenatal care is generally accessible, there were 10,257 infants in the United States and Puerto Rico who were exposed to a maternal HIV infection in utero who did not become infected and 244 exposed infants who did become infected.
Janet L. Mitchell was an American physician known for her advances in perinatal HIV/AIDS treatment. During the early days of the AIDS epidemic in the U.S. Mitchell developed protocols for health treatment of pregnant women who were HIV positive or at risk for developing AIDS. She advocated against mandatory testing and testifying before Congress, she advocated in favor of an inclusive approach to health care and social services. One of her innovations derived from a study that saw a 70% decrease in HIV transmission to babies when AZT was administered to their mothers during the pregnancy.
New York City was affected by the AIDS epidemic of the 1980s more than any other U.S. city. The AIDS epidemic has been and continues to be highly localized due to a number of complex socio-cultural factors that affect the interaction of the populous communities that inhabit New York.
HPA-23, sometimes known as antimonium tungstate, is an antiretroviral drug that was used for the treatment of HIV infection. It achieved widespread publicity as an effective treatment for HIV and AIDS beginning in 1984, just one year after HIV was first identified. Later testing failed to demonstrate any efficacy and some patients suffered serious side effects from the drug, including liver failure.
Jeffrey T. Parsons is an American psychologist, researcher, and educator; he was a Distinguished Professor of Psychology at Hunter College and The Graduate Center of the City University of New York (CUNY) and was the Director of Hunter College's Center for HIV/AIDS Educational Studies & Training, which he founded in 1996. Parsons was trained as a developmental psychologist and applied this training to understand health, with a particular emphasis on HIV prevention and treatment. He was known for his research on HIV risk behaviors of gay, bisexual, and other men who have sex with men (GBMSM), HIV-related syndemics, and sexual compulsivity. He resigned his positions at CUNY on July 3, 2019, following a year-long university investigation of misconduct allegations against him. In 2023, the U.S. Attorney's Office announced that he was required to pay a $375,000 settlement for engaging in fraud against the federal government for many years.
Many women have been infected with the HIV/AIDS virus. The majority of HIV/AIDS cases in women are directly influenced by high-risk sexual activities, injectional drug use, the spread of medical misinformation, and the lack of adequate reproductive health resources in the United States. Women of color, LGBT women, homeless women, women in the sex trade, and women intravenous drug users are at a high-risk for contracting the HIV/AIDS virus. In an article published by the Annual Review of Sociology, Celeste Watkins Hayes, an American sociologist, scholar, and professor wrote, "Women are more likely to be forced into survival-focused behaviors such as transactional sex for money, housing, protection, employment, and other basic needs; power-imbalanced relationships with older men; and other partnerings in which they cannot dictate the terms of condom use, monogamy, or HIV." The largest motivator to become part of the sex trade was addiction, the second largest being basic needs, and the third was to support their children/family.
Francine Cournos is Professor of Clinical Psychiatry at the Columbia University Mailman School of Public Health. Cournos is also Principal Investigator of the Northeast Caribbean AIDS Education and Training Center at the HIV Center for Clinical and Behavioral Studies.
James M. Oleske is an American pediatrician and HIV/AIDs researcher who is the emeritus François-Xavier Bagnoud (FXB) Professor of Pediatrics at Rutgers New Jersey Medical School in Newark, New Jersey. He is best known for his pioneering work in identifying HIV/AIDS as a pediatric disease, and treating and researching it beginning in the 1980s. He published one of the first articles identifying HIV/AIDS in children in JAMA in 1983 and was a co-author of one of the articles by Robert Gallo and others identifying the virus in Science in 1984.
Mary Goretti Boland, MSN, RN, FAAN is a Pediatric Nurse and Doctor of Public Health, and a Fellow of the American Academy of Nursing. She is nationally known for her work developing innovative healthcare programs for underserved children with HIV/AIDS and other chronic diseases. In 1978, Boland staffed an innovative mobile health screening van for the Ironbound Community Health Project in Newark, New Jersey. She became director of the AIDS program at Children's Hospital of New Jersey and served as the coordinator for the Children's AIDS program (CHAP) at United Hospitals Medical Center in Newark. She served on the AIDS Advisory Committee in New Jersey and the National AIDS Advisory Committee. The United States Department of Health and Human Services gave her an award for her work in pediatric AIDS/HIV treatment.
References
- 1 2 Scott, Janny; Leslie Kaufman (July 17, 2005). "Belated Charge Ignites Furor Over AIDS Drug Trial". The New York Times .
- ↑ Foderaro, Lisa (January 27, 2009). "Study Refutes Claims on AIDS Drug Trials". The New York Times .
- ↑ Holmwood, Leigh (October 23, 2007). "'Serious concern' at BBC over flawed HIV film". The Guardian .
- ↑ "Summaries of upheld complaints" (PDF). BBC Editorial Complaints Unit. Archived from the original on May 10, 2019. Retrieved March 28, 2014.
{{cite web}}: CS1 maint: bot: original URL status unknown (link)